Mini-review on edible mushrooms as source of dietary fiber: Preparation and health benefits  by Cheung, Peter C.K.
Aa
c
o
n
f
©
K
1
A
u
r
t
l
a
d
h
n
u
f
a
S
C
P
2
h
hAvailable  online  at  www.sciencedirect.com
Food Science and Human Wellness 2 (2013) 162–166
Mini-review on edible mushrooms as source of dietary fiber:
Preparation and health benefits
Peter C.K. Cheung ∗
Food and Nutritional Sciences, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China
Received 10 July 2013; received in revised form 23 July 2013; accepted 2 August 2013
bstract
Dietary fiber and high-fiber food products have attracted great attention because of their significant health benefits to consumers. Mushrooms
re valuable resources for food, medicine and nutraceuticals. Edible mushroom is considered as a novel source of dietary fiber. The dietary fiber
ontent and composition in edible mushroom vary greatly with its morphological stages including fruit body, mycelium and sclerotium. The focus
f this mini-review is on the preparation of dietary fiber from edible mushroom with emphasis on the sclerotium which has the highest level of
on-starch polysaccharides. The possible health benefits of mushroom dietary fiber in relationship with boosting the immune system, anticancer
unctions as well as the control of blood lipids and glucose levels are also discussed.
 2013 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  Deﬁnition  of  dietary  ﬁber
The definition of dietary fiber (DF) proposed by American
ssociation of Cereal Chemists (AACC) defines DF being made
p of edible part of plants or analogous carbohydrates that are
esistant to digestion and absorption in the human small intes-
ine as well as having beneficial physiological effects such as
axation, blood glucose attenuation and/or blood cholesterol
ttenuation [1]. More specifically, dietary fiber means carbohy-
rate polymers with ten or more monomeric units, which are not
ydrolyzed by the endogenous enzymes in humans [2]. These
on-digestible carbohydrate (NDC) polymers should occur nat-
rally in the food as consumed and have been obtained from
ood raw material by physical, enzymatic or chemical means
nd which have been shown to have a physiological effect of∗ Corresponding author at: Food and Nutritional Sciences, School of Life
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vidence to competent authorities [2].
.  Demand  for  DF  and  its  products
The increasing public awareness of DF’s potential health
enefits has greatly encouraged food manufacturers to develop
 wide range of fiber-enriched or fiber-fortified food products
3,4]. Nowadays, most DF ingredients (such as cereals-based,
ruits-based, and legumes-based DF) are originated from the by-
roducts of their corresponding food processing (e.g.  milling,
uice extraction, de-hulling, etc.) followed by different refining
teps (such as grinding, sieving, bleaching, defatting, etc.) in
rder to meet a wide range of customers’ requirements [5–7].
ecause of the highly competitive market of fiber-enriched food
roducts, exploration of alternative source of DF as well as DF
reparation method is urgent needed [8].
.  DF  and  human  health
It has been demonstrated by extensive research in the past
hree decades that sufficient DF intake has benefits for health
aintenance and disease prevention including cardiovascular
isease, diabetes, cancer and weight regulation [9–13]. There-
ore, DF research has drawn much attention recently, particularly
n the growing nutraceutical industry [14,15]. DF of differ-
nt origins has different structures, chemical composition, and
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Table 1
Proximate composition of some common mushroom species.a
Species Common names Crude proteinb Crude fat Carbohydratec Crude fiberd Ash Reference
Agaricus bisporus Button Mushroom 23.9-34.8 1.7-8.0 51.3-62.5 8.0-10.4 7.7-12.0 [23]
Auricularia auricula-judae Black Fungus 8.1 1.5 81.0 6.9 9.4 [23]
Boletus edulis Cep 29.7 3.1 51.7 8.0 5.3 [23]
Cantharellus cibarius Chanterelle 21.5 5.0 64.9 11.2 8.6 [23]
Grifola frondosa Maitake 21.1 3.1 58.8 10.1 7.0 [24]
Hericium erinaceus Monkeyhead 22.3 3.5 57.0 7.8 9.4 [24]
Lentinus edodes Shiitake 13.4-17.5 4.9-8.0 67.5-78.0 7.3-8.0 3.7-7.0 [23]
Pleurotus ostreatus Oyster Mushroom 10.5-30.4 1.6-2.2 57.6-81.8 7.5-8.7 6.1-9.8 [23]
Tremella fuciformis White Jelly Fungus 4.6 0.2 94.8 1.4 0.4 [23]
Tricholoma giganteum Matsutake 16.1 4.3 70.1 4.5 5.0 [24]
Tuber melanosporum Black Truffle 23.3 2.2 66.2 27.9 8.3 [23]
Vovariella volvacea Straw Mushroom 30.1 6.4 50.9 11.9 12.6 [23]
a All data presented as percentage of dry weight.
b The nitrogen factor used for crude protein calculation was 4.38.
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Table 2
Composition of dietary fiber in some cultivated mushrooms (% dry matter).
Mushroom species TDF (%) IDF (%) SDF (%)
Aa 26.7 ± 1.51 26.2 ± 1.29 0.51 ± 0.22
Ab 29.6 ± 3.52 27.6 ± 2.29 1.93 ± 1.24
Ac 36.4 ± 1.01 34.9 ± 0.95 1.52 ± 1.53
Cc 34.6 ± 5.28 32.8 ± 4.20 1.79 ± 1.13
Fv 38.2 ± 2.77 33.8 ± 1.93 4.42 ± 0.99
Gf 44.0 ± 1.55 43.1 ± 1.43 0.91 ± 0.13
He 34.0 ± 0.98 31.8 ± 0.56 2.12 ± 0.42
Hm 32.0 ± 1.35 30.1 ± 1.60 1.89 ± 0.26
Hr 26.9 ± 0.84 23.6 ± 0.29 3.25 ± 0.93
Lg 34.8 ± 0.53 34.3 ± 0.76 0.50 ± 0.26
Pa 30.8 ± 0.48 27.7 ± 0.67 3.08 ± 0.20
Pn 37.9 ± 0.79 34.8 ± 0.77 3.15 ± 0.11
Sra 28.4 ± 0.91 26.2 ± 0.80 2.26 ± 0.31
Agrocybe aegerita (Aa); Agaricus blazei (Ab); Agrocybe chaxinggu (Ac); Copri-
nus comatus (Cc); Flammulina velutipes (Fv); Grifola frondosa (Gf); Hericium
erinaceus (He); Hypsizigus marmoreus (Hm); Hericium ramosum (Hr); Lenti-
nus giganteus (Lg); Pholiota adiposa (Pa); Pholiota namkeo (Pn); Stropharia
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[c The carbohydrate content was calculated by subtracting difference.
d The crude fiber contains mainly the water-insoluble fiber fraction.
hysico-chemical properties that would exhibit different nutri-
ional, technological and physiological benefits [16,17].
.  Mushrooms  as  source  of  DF
Compared to other conventional sources of DF, such as cere-
ls, fruits, legumes and vegetables, mushrooms or fungi are
nderutilized [7,8]. In fact, edible mushrooms or macrofungi
re a rich source of some novel DFs that have various beneficial
ealth effects to humans which are discussed below.
Mushrooms are defined as fungi that have distinctive and vis-
ble fruiting bodies [18] and they include edible and medicinal
nes. The fruiting bodies of edible mushrooms (e.g.  Lentinus
dodes) are mainly consumed in their flesh or dried form, while
edicinal mushrooms (e.g.  Ganoderma  lucidum) are non-edible
ungi that have biopharmaceutical applications due to the bioac-
ive components such as polysaccharides and triterpenoids that
hey contain.
While plant cell walls are major sources of DF, mushroom
ell walls can also be considered as DF. Mushroom cell walls
ontain a mixture of fibrillar and matrix components which
nclude chitin (a straight-chain (1→4)-β-linked polymer of
-acetyl-glucosamine) and the polysaccharides such as (1→3)-
-D-glucans and mannans, respectively [19]. These mushroom
ell wall components are non-digestible carbohydrates (NDCs)
hat are resistant to human enzymes and can be considered as
ource of DF.
Carbohydrate is a major component in mushrooms and its
otal content ranges from 35% to 70% dry weight (DW) with
ariations in different species (Table 1) [20,21]. Most of the car-
ohydrates in mushrooms are NDCs including oligosaccharides
uch as trehalose and cell wall polysaccharides such as chitin,
-glucans and mannans. The level of chitin found in different
ushrooms is usually only a few % dry matter (DM), while theontent of β-glucans can be much higher [22].
There is large variation in the DF content of mushrooms
etween different species (Table 2). Mushroom DF is consti-
uted mainly by water-insoluble ones (IDF), with chitin and
a
s
c
rugoso-annulata (Sra). Modified from Ref. [22].
-glucans being the most representative ones, while the level
f water-soluble ones (SDF) is usually less than 10% DM as
hown in Table 2. Consumption of edible mushrooms as part of
ur daily diet can easily provide up to 25% of the recommended
ietary intake of DF [20].
.  Mushroom  sclerotia  as  novel  DF
Some mushrooms can develop a morphological form called
clerotium which has a compact mycelial structure under unfa-
orable conditions and remain dormant until the environment is
uitable for its development of fruiting bodies for reproduction
25]. The major cell wall components of mushroom sclerotium
re chitin and β-glucans with β-1,3 backbone and β-1,6-linked
ide branches [26–28]. These sclerotial cell wall components
annot be digested by human enzymes and therefore can be
egarded as novel source of DF by definition [1,2].
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Our previous studies have found that the total DF content
f three mushroom sclerotia, namely Pleurotus  tuber-regium,
olyporus rhinocerus  and Wolﬁporia  cocos  was extremely high
nd could be well over 80% DM [28–30]. In the sclerotium of
. tuber-regium, IDF constituted almost 80% DM while SDF
ad only 2.50% DM [30]. Such high level of total DF content
ound in mushroom sclerotium is similar to that of commercial
F obtained from conventional sources such as seaweeds and
egumes [31]. It was found that the predominant sugar residues in
he DF of the sclerotium of P.  tuber-regium  was glucose (about
0%) followed by about 6% glucosamine, confirming that β-
lucans and chitin are the main cell wall polysaccharides [29].
.  Preparation  of  mushroom  DF
The main principles of DF preparation are the removal of
on-DF materials by either enzymatic or chemical methods.
DF is extracted by water or other aqueous solution with pH
ontrol while IDF is usually recovered as insoluble residue. The
ost widely accepted method for total DF determination is the
OAC enzymatic-gravimetric methods 985.29 [32] involving
he use of three analytical enzymes: heat stable α-amylase (EC
.2.1.1), protease (EC 3.4.21.14) as well as amyloglucosidase
EC 3.2.1.3) to remove all the non-fiber materials including
tarch and protein. Chemical methods for DF preparation are
sually simple but non-specific with possible loss or degradation
f DF.
Comparing to fruit body and mycelium, mushroom scle-
otium has the highest level of NDCs and potential to an ideal
ource of commercial DF. Recently, an enzymatic procedure
odified from the AOAC methods 985.29 for preparing some
ovel DF from three mushroom sclerotia including Pleurotus
uber-regium (PTR), Polyporus  rhinocerus  (PR) and Wolﬁporia
ocos (WC) using analytical and industrial food grade enzymes
as developed in our laboratories [30,33]. The effects of these
nzymes on both the yield and NDC composition of sclero-
ial DF were compared. It was found that the use of industrial
rade enzymes in the preparation the total DF could give a very
igh yield of sclerotial DFs [PTR: 81.2%; PR: 86.5%; WC:
6.2% DW] with purity that was comparable to that of analyti-
al enzymes [33,34]. Moreover, sclerotial DF also has functional
roperties such as water and oil holding, emulsifying and min-
ral binding that are essential for its application in food products
30]. Together with the advantages of energy saving, environ-
ental friendly, non-toxic, and specific, the enzymatic approach
n the scale-up preparation of the sclerotial DF in food industry
s worthy for further exploration.
.  Health  beneﬁts  of  mushroom  DF
Compared to Asian countries such as China, Korea and Japan,
he application of medicinal mushrooms in the Western countries
s more recent [35–37]. Medicinal mushrooms are character-
zed by having cell wall polysaccharides and proteins as well
s fungal secondary metabolites including lignins, triperpenes
nd phenolics that have a broad spectrum of pharmacological
ctivities [35,36]. On the other hand, edible mushrooms are rich
i
a
t
hman Wellness 2 (2013) 162–166
n DF with NDCs including β-glucans, polysaccharide–protein
omplexes (PSPC) and chitin that also has a wide range of health
enefits to humans. The beneficial health effects of mushroom
F that have been studied include the immune-enhancing and
ntitumor activity as well as blood glucose and lipid attenu-
tion [38–43]. Some commercial β-glucans isolated from the
ruiting bodies of Lentinus  edodes  (lentinan) and Grifola  fron-
osa (D-fraction) as well as PSPC from Trametes  versicolor
ere shown to stimulate the non-specific immune system in ani-
als to inhibit cancer cell proliferation [38]. They are regarded
s immunomodulators and have been used as adjuvant in can-
er therapy with certain success [44–46]. It has recently been
hown that a PSPC isolated from an edible mushroom Pleurotus
ulmonarius can suppress in  vitro  and in  vivo  liver cancer devel-
pment and progression through inhibition of VEGF-induced
I3K/AKT signaling pathway [47]. Apart from β-glucans, het-
ropolysaccharides such as glucuronoxylomannan isolated from
he fruiting bodies of Tremella  fuciformis  and Tremella  mesen-
erica exhibited immunomodulatory and hypoglycemic effects
n animal studies [42,48].
.  Biopharmacological  effect  of  sclerotial  DF
As mentioned earlier, mushroom sclerotium is a rich source
f DF source and contains extremely high level of β-glucans
>80% DM) that can have a number of biopharmacological
ffects that are beneficial to humans [49]. It has been reported
hat both the innate and adaptive immunity of the host could be
timulated by sclerotial β-glucans to trigger strong immunomod-
latory mediated by cytokine production and signaling cascade
s well as direct inhibition of cancer cells via cell cycle
rrest and cytotoxicity [50–54]. Native sclerotial β-glucans iso-
ated from the P. tuber-regium  could induce apoptosis of acute
romyelocytic leukemic cells (HL-60) [52], while their car-
oxymethylated counterparts could induce both in  vitro  cell
ycle arrest and apoptosis of human breast cancer cells (MCF-
) mediated by the down-regulation of cyclin D1 and cyclin E
xpressions at the G1 phase as well as and the up-regulation
f the expression of the Bax/Bcl-2 ratio, respectively [53].
hemical modifications of native sclerotial β-glucans from P.
uber-regium  by carboxymethylaion and sulfation could enhance
he immunomodulatory and anti-tumor activities of these new
erivatives when they were administered intraperitoneally on
ALB/c mice bearing Sarcoma 180 solid tumor [55,56].
The mechanisms of the in  vivo  immunomodulatory and anti-
umor activities of sclerotial β-glucans are not well understood
ut it is very likely that some kind of surface receptor inter-
ctions between the immune cells and β-glucans might have
een involved. Dectin-1 has been identified as a β-glucan recep-
or found on the surface of a number of innate immune cells
ncluding monocytes, macrophages, NK cells and dendritic
ells in human and mice recently [57,58]. Dectin-1 receptor
as able to recognize β-glucans derived from yeast to triggermmunomodulation in both humans and mice [59,60]. The new
pproach of identifying similar or novel β-glucans receptor(s)
hat are specific to sclerotial β-glucans on the surface of innate
uman primary cells would be a promising new one and would
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rovide new insights in explaining the immunomodulatory and
nti-tumor effects of sclerotial β-glucans [50].
There are other biopharmacological activities of sclerotial
olysaccharides isolated from P.  tuber-regium  that have been
eported. These include hepatic protection against acute liver
njury induced by carbon tetrachloride in mice and lowering
f fasting blood glucose level in alloxan-induced diabetic mice
61]. Chemically modified sclerotial β-glucans derived from P.
uber-regium also have interesting biological activities that could
ot be found in their native counterparts. For instance, sulfated
clerotial β-glucans isolated from P.  tuber-regium  possessed
nti-viral activity against human simplex virus including HSV-1
nd HSV-2 which was probably due to their increased aqueous
olubility and more opened chain conformation compared to
he native ones [62,63]. Both sulfated and carboxymethylated
clerotial β-glucans obtained from P.  tuber-regium  could scav-
nge superoxide and hydroxyl radicals and protect the oxidative
amage of liver mitochondria and DNA [64–66].
Most recently, it has been demonstrated that sclerotial β-
lucans can be utilized by human colonic bacteria in  vitro  and
herefore they have the potential to be used as novel prebiotics
hat can influence human gut health by selectively modulating
he growth of probiotic bacteria including bifidobacteria and lac-
ic acid bacteria [67,68]. The colonic fermentation of sclerotial
-glucans isolated from P.  tuber-regium  could also enhance the
bsorption of calcium and magnesium in ovariectomized rats
hich might have the health implication of improving mineral
bsorption in the human gut [69].
.  Conclusion
In general, edible mushrooms are underutilized to be a source
f DF at the moment. Given the many mushroom species that
ave not yet been studied, it is anticipated that more new methods
f preparation of mushroom DF and high fiber products enriched
ith mushroom DF will be developed. With advances in molec-
lar biology nutrigenomics, the structure–function relationship
f the bioactive components in mushroom DF, especially β-
lucans, can be elucidated more clearly. This would greatly
acilitate the application of mushroom DF as functional food
ngredient or product that can provide various health benefits to
umans in the future.
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